Outcome of pregnancies complicated by severe ovarian hyperstimulation syndrome (OHSS): A follow-up beyond the second trimester

Human Reproduction

Volumn 20, Issue 4, 2005, Pages 910-914

  Wiser, A ^a,b   Levron, J ^a,b   Kreizer, D ^a,b   Achiron, R ^a,b   Shrim, A ^a,b   Schiff, E ^a,b   Dor, J ^a,b   Shulman, Adrian ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

GDM; Maternal fetal outcome; OHSS; Pregnancy; Second trimester

Indexed keywords

ADULT; ARTICLE; CHILDBIRTH; CONCEPTION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FERTILIZATION IN VITRO; FOLLOW UP; HUMAN; INCIDENCE; LAPAROSCOPIC SURGERY; LAPAROSCOPY; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MEDICAL ASSESSMENT; OUTCOMES RESEARCH; OVARY DISEASE; OVARY HYPERSTIMULATION; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; TWIN PREGNANCY;

EID: 18744414804     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh713     Document Type: Article

References (23)

1. Abramov Y, Elchalal U and Schenkar JG (1998) Obstetric outcome of in vitro fertilized pregnancies complicated by severe ovarian hyperstimulation syndrome: a multicenter study. Fertil Steril 70,1070-1076.
2. ACOG Technical Bulletin (1995) Diabetes and pregnancy. Number 200, December 1994. Diabetes in Pregnancy Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 48,331-339.
3. Delvigne, A, Kostyla K, De Leener A, Lejeune B, Cantiniaux B, Bergmann P and Rozenberg S (2002) Metabolic characteristics of women who developed ovarian hyperstimulation syndrome. Hum Reprod 17,1994-1996.
4. Elchalal U and Schenker JG (1997) The pathophysiology of ovarian hyperstimulation syndrome: views and ideas. Hum Reprod 12,1129-1137.
5. Filep JG, Sirois MG, Foldes-Filep E, Rousseau A, Plante GE, Fournier A, Yano M and Sirois P (1993) Enhancement by endothelin-1 of microvascular permeability via the activation of ETA receptor. Br J Pharmacol 109,880-886.
6. Golan A, Ron-El R, Herman A, Soffer Y, Weinraub Z and Caspi E (1989) Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 44,430-440.
7. Gorkemli H, Camus M and Clasen K (2002) Adnexal torsion after gonadotrophin ovulation induction for IVF or ICSI and its conservative treatment. Arch Gynecol Obstet 267,4-6.
8. Heimarch J, Krawczenko A and Dus D (2000) Endothelin-1 (ET-1) as a mediator of pregnancy-induced hypertension (PIH). Ginekol Pol 73, 512-516.
9. Kashyap S and Claman P (2000) Polycystic ovary disease and the risk of pregnancy-induced hypertension. J Reprod Med 45,991-994.
10. Kamada S, Kubota T, Taguchi M and Aso T (1993) High level of immunoreactive endothelin-1 in human follicular fluids. Hum Reprod 8,674-677.
11. Levy T, Dicker D, Shalev J, Dekel A, Farhi J, Peleg D and Ben-Rafael Z (1995) Laparoscopic unwinding of hyperstimulated ischaemic ovaries during the second trimester of pregnancy. Hum Reprod 10,1478-1480.
12. Maman E, Lunenfeld E, Levy A, Vardi H and Potashnik G (1998) Obstetric outcome of singleton pregnancies conceived by in vitro fertilization and ovulation induction compared with those conceived spontaneously. Fertil Steril 70,240-245.
13. Mashiach S, Bider D, Moran O, Goldenberg M and Ben-Rafael Z (1990) Adnexal torsion of hyperstimulated ovaries in pregnancies after gonadotropin therapy. Fertil Steril 53,76-80.
14. Mathur RS and Jenkins JM (2000) Is ovarian hyperstimulation syndrome associated with a poor obstetric outcome? BJOG 107,943-946.
15. Morris RS, Miller C, Jacobs L and Miller K (1995) Conservative management of ovarian hyperstimulation syndrome. J Reprod Med 40,711-714.
16. National Diabetes Care Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28, 1039-1057.
17. Navot D, Berg PA and Laufer N (1992) Ovarian hyperstimulation, syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 58,249-261.
18. Raziel A, Friedler S, Schachter M, Strassburger D, Mordechai E and Ron-El R (2002) Increased early pregnancy loss in IVF patients with severe ovarian hyper-stimulation syndrome. Hum Reprod 17,107- 110.
19. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy (2000) Am J Obstet Gynecol 183,S1-S22
20. Roach VJ, Hin LY, Tam WH, Ng KB and Rogers MS (2000) The incidence of pregnancy-induced hypertension among patient with carbohydrate intolerance. Hypertens Pregnancy 19,183-189.
21. Salamalekis E, Makrakis E, Vitoratos N, Chassiakos D, Baka S and Creatsas G (2004) Insulin levels, insulin resistance, and leptin levels are not associated with the development of ovarian hyperstimulation syndrome. Fertil Steril 82,244-246.
22. Ventura SJ, Martin JA, Curtin SC, Mathews TJ and Park MM (2000) Births: final data for 1998. National Vital Statistics Reports, Vol. 48. National Center Health Statistics, Hyattsville, MD, USA, No. 3.
23. Xiong X, Saunders LD, Wang FL and Demianczuk NN (2001) Gestational diabetes mellitus: prevalence, risk factors, maternal and infant outcomes. Intl J Gynaecol Obstet 75,221-228.